lovastatin has been researched along with Neoplasm Metastasis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, S; Bhattacharya, S; Dauer, P; Dudeja, V; Giri, B; Gupta, VK; Kesh, K; Nomura, A; Saluja, A; Sharma, NS | 1 |
| Brossart, P; Fröhlich, E; Wahl, R | 1 |
| Ho, BY; Pan, TM | 1 |
| Fritz, G; Hamalukic, M; Huelsenbeck, J; Kaina, B; Schad, A; Wirtz, S | 1 |
| Feleszko, W; Grzela, T; Hoser, G; Jakóbisiak, M; Jalili, A; Korczak-Kowalska, G; Lasek, W; Młynarczuk, I; Olszewska, D | 1 |
| Alonso, DF; Bublik, DR; Farina, HG; Gomez, DE | 1 |
| Chan, KK; Oza, AM; Siu, LL | 1 |
| Beckedorf, A; Bieberich, E; Silva, J | 1 |
| Binda, MM; Bonfil, RD; Gervasoni, SI; Hinrichsen, LI; Matar, P; Rozados, VR; Scharovsky, OG | 1 |
| Blanock, K; Gupta, V; Jani, JP; Katoh, A; Singh, SV; Specht, S; Stemmler, N | 1 |
| Kim, BS; Kim, TS; Min, JS; Noh, SH; Rha, SY; Roh, JK; Yoo, NC | 1 |
| Matar, P; Roggero, EA; Rozados, VR; Scharovsky, OG | 1 |
1 review(s) available for lovastatin and Neoplasm Metastasis
| Article | Year |
|---|---|
The statins as anticancer agents.
Topics: Anticholesteremic Agents; Antineoplastic Agents; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Models, Biological; Neoplasm Metastasis | 2003 |
11 other study(ies) available for lovastatin and Neoplasm Metastasis
| Article | Year |
|---|---|
Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity.
Topics: AC133 Antigen; Animals; Caveolin 1; Cell Line, Tumor; Cholesterol; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Membrane Microdomains; Mice, Inbred C57BL; Mice, Nude; Neoplasm Metastasis; Neoplastic Stem Cells; Paclitaxel; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Iodides; Lovastatin; Neoplasm Metastasis; Oxides; Pyrazines; Sirolimus; Thymus Gland; Thyroid Neoplasms; Tretinoin | 2009 |
The Monascus metabolite monacolin K reduces tumor progression and metastasis of Lewis lung carcinoma cells.
Topics: Animals; Carcinoma, Lewis Lung; Fermentation; Lovastatin; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Monascus; Neoplasm Metastasis; Oryza; Plant Extracts; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2009 |
Rac1-regulated endothelial radiation response stimulates extravasation and metastasis that can be blocked by HMG-CoA reductase inhibitors.
Topics: Animals; Base Sequence; Blotting, Western; DNA Primers; E-Selectin; Electrophoresis, Polyacrylamide Gel; Extravasation of Diagnostic and Therapeutic Materials; Glycyrrhizic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Polymerase Chain Reaction; rac1 GTP-Binding Protein; Whole-Body Irradiation | 2011 |
Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Doxorubicin; Drug Synergism; Female; Humans; In Situ Nick-End Labeling; Lovastatin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Metastasis; Tumor Cells, Cultured | 2002 |
Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells.
Topics: Animals; Antineoplastic Agents; Cytoskeleton; Lovastatin; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Tumor Cells, Cultured | 2002 |
Osteoblast-derived oxysterol is a migration-inducing factor for human breast cancer cells.
Topics: Arachidonic Acid; Aspirin; Breast Neoplasms; Cell Membrane; Cell Movement; Cholesterol; Chromatography, High Pressure Liquid; Coculture Techniques; Culture Media, Conditioned; Dinoprostone; Electrophoresis, Polyacrylamide Gel; HSP70 Heat-Shock Proteins; Humans; Insulin-Like Growth Factor I; Lipid Metabolism; Lovastatin; MAP Kinase Signaling System; Microscopy, Fluorescence; Neoplasm Metastasis; Osteoblasts; Phospholipids; Phosphorylation; Prostaglandins B; Protein Transport; Proto-Oncogene Proteins p21(ras); Reverse Transcriptase Polymerase Chain Reaction; Sepharose; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sphingolipids; Sterols; Trypsin; Tumor Cells, Cultured | 2003 |
Lovastatin enhances the antitumoral and apoptotic activity of doxorubicin in murine tumor models.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Doxorubicin; Drug Synergism; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Rats | 2008 |
Metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis.
Topics: Animals; Cell Adhesion; Cell Division; Female; Lovastatin; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Tumor Cells, Cultured | 1993 |
Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer.
Topics: Anticoagulants; Antineoplastic Agents; Carrier Proteins; Cell Adhesion; Cell Division; Cell Movement; Cytokines; Doxorubicin; Drug Synergism; Gelatinases; Humans; Lovastatin; Matrix Metalloproteinase 2; Metalloendopeptidases; Mevalonic Acid; Midkine; Neoplasm Metastasis; Pentosan Sulfuric Polyester; Peptide Hydrolases; Phenotype; Plasminogen Activator Inhibitor 1; Protease Inhibitors; Stomach Neoplasms; Tissue Inhibitor of Metalloproteinase-2; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1999 |
Lovastatin inhibits tumor growth and metastasis development of a rat fibrosarcoma.
Topics: Animals; Antineoplastic Agents; Cell Division; Cholesterol; Fibrosarcoma; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Neoplasm Metastasis; Rats; Rats, Inbred Strains; Sarcoma, Experimental | 1998 |